Shareholding disclosure
Kuros Biosciences AG
Declared position
56.19%
Threshold
Crossed downwards
Timeline
Published
29.12.2016
Transaction
18.12.2016
Voting rights breakdown
Voting rights acquired0.53%
Voting rights sold56.19%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAGCS00026
Beneficial owner
Kuros Biosciences AG
Declared address
Kuros Biosciences AG, 8952 Schlieren
Date of transfer of equity securities: early 2017 Conditional Obligation to issue new shares pursuant to a Combination Agreement entered with shareholders of Xpand Biotechnology BV on 18 December 2016: 1'365'000 shares of Kuros Biosciences Ltd to be issued at closing of the Combination Agreement in early 2017 and 740'000 shares of Kuros Biosciences Ltd to be issued an the achievement of certain product approval milestones.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open